搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
10 小时
on MSN
World’s largest proteins study ‘invaluable’ for understanding disease – experts
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Multiple Sclerosis News Today
1 天
OCS-05 shows safety, aids vision with optic neuritis in Phase 2 trial
OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...
2 天
on MSN
Richard Cohen, Meredith Vieira's journalist husband, dies at 76 after living with MS for 50 ...
Richard Cohen, the journalist husband of broadcaster Meredith Vieira, has died at 76, more than 50 years after an MS ...
Multiple Sclerosis News Today
3 天
Long-term Tecfidera slows MS disability progression in large trial
Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...
Bennington Banner
3 天
Memory Clinic Welcomes Family Nurse Practitioner Penny Bruso
BC, MSCN has joined the Memory Clinic staff. Penny is board-certified in Family Practice with focused training in certain ...
Pharmaceutical Technology
4 天
ANK-700 by Anokion for Relapsing Remitting Multiple Sclerosis (RRMS): Likelihood of Approval
ANK-700 is under clinical development by Anokion and currently in Phase I for Relapsing Remitting Multiple Sclerosis (RRMS).
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈